How important is the linearity assumption in a sample size calculation for a randomised controlled trial where treatment is anticipated to affect a rate of change?
How important is the linearity assumption in a sample size calculation for a randomised controlled trial where treatment is anticipated to affect a rate of change?
复制标题
DOI:
10.1186/s12874-023-02093-2
复制
发表时间:
2023-11-21
影响因子:
4
通讯作者:
中科院分区:
文献类型:
--
作者:
For certain conditions, treatments aim to lessen deterioration over time. A trial outcome could be change in a continuous measure, analysed using a random slopes model with a different slope in each treatment group. A sample size for a trial with a particular schedule of visits (e.g. annually for three years) can be obtained using a two-stage process. First, relevant (co-) variances are estimated from a pre-existing dataset e.g. an observational study conducted in a similar setting. Second, standard formulae are used to calculate sample size. However, the random slopes model assumes linear trajectories with any difference in group means increasing proportionally to follow-up time. The impact of these assumptions failing is unclear. We used simulation to assess the impact of a non-linear trajectory and/or non-proportional treatment effect on the proposed trial’s power. We used four trajectories, both linear and non-linear, and simulated observational studies to calculate sample sizes. Trials of this size were then simulated, with treatment effects proportional or non-proportional to time. For a proportional treatment effect and a trial visit schedule matching the observational study, powers are close to nominal even for non-linear trajectories. However, if the schedule does not match the observational study, powers can be above or below nominal levels, with the extent of this depending on parameters such as the residual error variance. For a non-proportional treatment effect, using a random slopes model can lead to powers far from nominal levels. If trajectories are suspected to be non-linear, observational data used to inform power calculations should have the same visit schedule as the proposed trial where possible. Additionally, if the treatment effect is expected to be non-proportional, the random slopes model should not be used. A model allowing trajectories to vary freely over time could be used instead, either as a second line analysis method (bearing in mind that power will be lost) or when powering the trial. The online version contains supplementary material available at 10.1186/s12874-023-02093-2.
登录
查看更多内容
DOI:
10.1177/1536867x211045512
发表时间:
2021-09
期刊:
The Stata journal
影响因子:
--
作者:
Nash S;Morgan KE;Frost C;Mulick A
通讯作者:
Mulick A
影响因子:
158.5
作者:
Mintun, Mark A.;Lo, Albert C.;Skovronsky, Daniel M.
通讯作者:
Skovronsky, Daniel M.
DOI:
10.1212/nxi.0000000000000374
发表时间:
2017-09
期刊:
Neurology(R) neuroimmunology & neuroinflammation
影响因子:
--
作者:
Spain R;Powers K;Murchison C;Heriza E;Winges K;Yadav V;Cameron M;Kim E;Horak F;Simon J;Bourdette D
通讯作者:
Bourdette D
影响因子:
2.4
作者:
Moerbeek, Miriam
通讯作者:
Moerbeek, Miriam
影响因子:
168.9
作者:
Mullen, Michael;Jin, Xu Yu;Flather, Marcus
通讯作者:
Flather, Marcus